HIGHER PRICES FROM ENTRY: PRICING OF BRAND-NAME DRUGS

Jeffrey Perloff, Valerie Suslow and Paul J. Seguin

No 25104, CUDARE Working Papers from University of California, Berkeley, Department of Agricultural and Resource Economics

Abstract: When a new firm enters a market and starts selling a spatially-differentiated product, the prices of existing products may rise due to a better match between consumers and products. Entry may have three unusual effects. First, the new price is above the monopoly price if the two firms collude and may be above the monopoly price even if the firms play Bertrand. Second, the Bertrand and collusive price may be identical. Third, prices, combined profits, and consumer surplus may all rise with entry. Consistent with our theory, the real prices of some anti-ulcer drugs rose as new products entered the market.

Keywords: Demand and Price Analysis; Industrial Organization (search for similar items in EconPapers)
Pages: 36
Date: 1996
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (12)

Downloads: (external link)
https://ageconsearch.umn.edu/record/25104/files/wp778.pdf (application/pdf)

Related works:
Working Paper: Higher Prices from Entry: Pricing of Brand-Name Drugs (1995)
Working Paper: Higher Prices from Entry: Pricing of Brand-Name Drugs (1995)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ags:ucbecw:25104

DOI: 10.22004/ag.econ.25104

Access Statistics for this paper

More papers in CUDARE Working Papers from University of California, Berkeley, Department of Agricultural and Resource Economics Contact information at EDIRC.
Bibliographic data for series maintained by AgEcon Search ().